Bruce C. Cozadd

2018

In 2018, Bruce C. Cozadd earned a total compensation of $11.4M as Chairman and CEO at Jazz Pharmaceuticals, a 11% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$980,300
Option Awards$4,265,610
Salary$979,285
Stock Awards$5,204,786
Other$13,152
Total$11,443,133

Cozadd received $5.2M in stock awards, accounting for 45% of the total pay in 2018.

Cozadd also received $980.3K in non-equity incentive plan, $4.3M in option awards, $979.3K in salary and $13.2K in other compensation.

Rankings

In 2018, Bruce C. Cozadd's compensation ranked 549th out of 14,244 executives tracked by ExecPay. In other words, Cozadd earned more than 96.1% of executives.

ClassificationRankingPercentile
All
549
out of 14,244
96th
Division
Manufacturing
177
out of 5,759
97th
Major group
Chemicals And Allied Products
50
out of 2,122
98th
Industry group
Drugs
38
out of 1,811
98th
Industry
Pharmaceutical Preparations
26
out of 1,385
98th

Pay ratio

Bruce C. Cozadd's Pay$11,443,133
Median Employee's Pay$216,797
Pay Ratio

53

to 1

In 2018, the annual total compensation of Bruce C. Cozadd was $11,443,133.

The annual total compensation of the median employee at Jazz Pharmaceuticals was $216,797.

The ratio of Bruce C. Cozadd's pay to the pay of median employee was therefore 53 to one.

Source: SEC filing on June 14, 2019.

Cozadd's colleagues

We found four more compensation records of executives who worked with Bruce C. Cozadd at Jazz Pharmaceuticals in 2018.

2018

Daniel Swisher

Jazz Pharmaceuticals

Chief Operating Officer

2018

Suzanne Hooper

Jazz Pharmaceuticals

Former Executive Vice President and GC

2018

Matthew Young

Jazz Pharmaceuticals

Chief Financial Officer

2018

Michael Miller

Jazz Pharmaceuticals

Executive Vice President U.S Commercial

News

You may also like